Pfizer Plans to Increase Offer for AstraZeneca

According to an article in Bloomberg, Pfizer Inc. is planning to sweeten its bid for U.K. rival AstraZeneca Plc for a second time, people with knowledge of the matter said. Pfizer and its advisers are said to be crafting a new offer that would increase the value modestly above the current 50 pounds-a-share (about $84) level while bumping the cash portion, according to two of the people, who asked not to be identified. Pfizer is putting together a sweetened offer before it considers whether to make a hostile takeover attempt by bringing its proposal directly to AstraZeneca’s shareholders, the people said. Read the full story

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments